Skip to main content

Discovery Partners Sells Over-Allotment on Sale of Celera Genomics Shares

NEW YORK, May 14 (GenomeWeb News) - Discovery Partners International announced today that it has taken in $5.1 million from an over-allotment option in a public offering of its common stock.


DPI said that 1,083,300 over-allotment shares were purchased at the price of $5 per share, following on a public offering of the 7,220,000 shares that Celera Genomics recently sold. The Applera unit announced on Wednesday that it had sold its DPI stock for $32 million.


SG Cowen was the lead manager and Merriman Curhan Ford and Roth Capital Partners were co-managers for the offering.


The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.